Here is why Oragenics, Inc. (NYSE American: OGEN) stock surged early morning
Oragenics, Inc. (NYSE American: OGEN) shares +44.03% to $8860 rocked in the morning session Thursday as it announced that it had entered an agreement with Adjuvance Technologies Inc. for the use of adjuvant TQL1055 in the Terra CoV-2 vaccine against COVID-19. The adjuvants that vaccines are prepared with are added to enhance their immunogenicity. The […]